|

Ixekizumab Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Also known as: N/A (Not applicable), Taltz

Pipeline

Phase 2: 1

Top Sponsors

  • NHS Greater Glasgow and Clyde2
  • NYU Langone Health1

Indications

  • Arthritis3
  • Rheumatic Disease1
  • Psoriatic Plaque1
  • Obesity & Overweight1
  • Psoriatic Arthritis1

Other2 trials

Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
N/A
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

New York, New York1 trial

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NYU Langone Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.